U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from MedGen

Items: 1 to 20 of 227

1.
Complex phenotypic heterogeneity of combined hepatocellular-cholangiocarcinoma with a homogenous TERT promoter mutation
Sumie Ohni, Hiromi Yamaguchi, Yukari Hirotani, Yoko Nakanishi, Yutaka Midorikawa, Masahiko Sugitani, Tomohiro Nakayama, Makoto Makishima, Mariko Esumi
Am J Transl Res. 2024; 16(2): 690–699. Published online 2024 Feb 25. doi: 10.62347/CQJW7490
PMCID:
PMC10918120
ArticlePDF–2.0M
2.
Preoperative evaluation of MRI features and inflammatory biomarkers in predicting microvascular invasion of combined hepatocellular cholangiocarcinoma
Juan Zhang, Wei Dong, Wanmin Liu, Jiazhao Fu, Tian Liao, Yinqiao Li, Lei Huo, Ningyang Jia
Abdom Radiol (NY) 2024; 49(3): 710–721. Published online 2023 Dec 19. doi: 10.1007/s00261-023-04130-6
PMCID:
PMC10909765
ArticlePDF–1.1M
3.
Treating an Advanced Combined Hepatocellular-Cholangiocarcinoma with a Multikinase Inhibitor
Teresa Fraga, Nuno Bonito
Cureus. 2024 Feb; 16(2): e53394. Published online 2024 Feb 1. doi: 10.7759/cureus.53394
PMCID:
PMC10908305
ArticlePDF–514K
4.
Nodal recurrence mapping and clinical target volumes after resection of intrahepatic cholangiocarcinoma or combined hepatocellular-cholangiocarcinoma
Zhuanbo Yang, Liming Wang, Yirui Zhai, Jianjun Zhao, Feng Ye, Shulian Wang, Liming Jiang, Yan Song, Yongkun Sun, Ji Zhu, Yuan Tang, Yueping Liu, Yongwen Song, Hui Fang, Ning Li, Shunan Qi, Ningning Lu, Ye-Xiong Li, Hong Zhao, Bo Chen
Clin Transl Radiat Oncol. 2024 Mar; 45: 100749. Published online 2024 Feb 18. doi: 10.1016/j.ctro.2024.100749
PMCID:
PMC10904232
ArticlePDF–3.2M
5.
Comparison contrast-enhanced CT with contrast-enhanced US in diagnosing combined hepatocellular-cholangiocarcinoma: a propensity score-matched study
Jie Yang, Yun Zhang, Wu-yong-ga Bao, Yi-di Chen, Hanyu Jiang, Jia-yan Huang, Ke-yu Zeng, Bin Song, Zi-xing Huang, Qiang Lu
Insights Imaging. 2024 Dec; 15: 44. Published online 2024 Feb 14. doi: 10.1186/s13244-023-01576-6
PMCID:
PMC10866845
ArticlePDF–4.3M
6.
Combined Hepatocellular-Cholangiocarcinoma: Biology, Diagnosis, and Management
Liangtao Ye, Julia S. Schneider, Najib Ben Khaled, Peter Schirmacher, Carolin Seifert, Lea Frey, Yulong He, Andreas Geier, Enrico N. De Toni, Changhua Zhang, Florian P. Reiter
Liver Cancer. 2024 Feb; 13(1): 6–28. Published online 2023 Apr 24. doi: 10.1159/000530700
PMCID:
PMC10857821
ArticlePDF–1.7M
7.
Update on the Diagnosis and Treatment of Combined Hepatocellular Cholangiocarcinoma
Kai-Jian Chu, Yoshikuni Kawaguchi, Han Wang, Xiao-Qing Jiang, Kiyoshi Hasegawa
J Clin Transl Hepatol. 2024 Feb 28; 12(2): 210–217. Published online 2023 Nov 15. doi: 10.14218/JCTH.2023.00189
PMCID:
PMC10851068
ArticlePDF–3.3M
8.
Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinoma
Julien Calderaro, Narmin Ghaffari Laleh, Qinghe Zeng, Pascale Maille, Loetitia Favre, Anaïs Pujals, Christophe Klein, Céline Bazille, Lara R. Heij, Arnaud Uguen, Tom Luedde, Luca Di Tommaso, Aurélie Beaufrère, Augustin Chatain, Delphine Gastineau, Cong Trung Nguyen, Hiep Nguyen-Canh, Khuyen Nguyen Thi, Viviane Gnemmi, Rondell P. Graham, Frédéric Charlotte, Dominique Wendum, Mukul Vij, Daniela S. Allende, Federico Aucejo, Alba Diaz, Benjamin Rivière, Astrid Herrero, Katja Evert, Diego Francesco Calvisi, Jérémy Augustin, Wei Qiang Leow, Howard Ho Wai Leung, Emmanuel Boleslawski, Mohamed Rela, Arnaud François, Anthony Wing-Hung Cha, Alejandro Forner, Maria Reig, Manon Allaire, Olivier Scatton, Denis Chatelain, Camille Boulagnon-Rombi, Nathalie Sturm, Benjamin Menahem, Eric Frouin, David Tougeron, Christophe Tournigand, Emmanuelle Kempf, Haeryoung Kim, Massih Ningarhari, Sophie Michalak-Provost, Purva Gopal, Raffaele Brustia, Eric Vibert, Kornelius Schulze, Darius F. Rüther, Sören A. Weidemann, Rami Rhaiem, Jean-Michel Pawlotsky, Xuchen Zhang, Alain Luciani, Sébastien Mulé, Alexis Laurent, Giuliana Amaddeo, Hélène Regnault, Eleonora De Martin, Christine Sempoux, Pooja Navale, Maria Westerhoff, Regina Cheuk-Lam Lo, Jan Bednarsch, Annette Gouw, Catherine Guettier, Marie Lequoy, Kenichi Harada, Pimsiri Sripongpun, Poowadon Wetwittayaklang, Nicolas Loménie, Jarukit Tantipisit, Apichat Kaewdech, Jeanne Shen, Valérie Paradis, Stefano Caruso, Jakob Nikolas Kather
Nat Commun. 2023; 14: 8290. Published online 2023 Dec 14. doi: 10.1038/s41467-023-43749-3
PMCID:
PMC10719304
ArticlePDF–2.2M
9.
Nomogram based on clinical and preoperative CT features for predicting the early recurrence of combined hepatocellular-cholangiocarcinoma: a multicenter study
Chao Zheng, Xin-tao Gu, Xiao-li Huang, Yu-chen Wei, Lu Chen, Ning-bin Luo, Hua-shan Lin, Liao Jin-yuan
Radiol Med. 2023; 128(12): 1460–1471. Published online 2023 Sep 25. doi: 10.1007/s11547-023-01726-2
PMCID:
PMC10700214
ArticlePDF–1.3M
10.
Case report: Remarkable response to sintilimab, lenvatinib, and nab-paclitaxel in postoperative metastatic chemotherapy-resistant combined hepatocellular-cholangiocarcinoma
Nan Zhou, Chuan-Fen Lei, Si-Rui Tan, Qi-Yue Huang, Shun-Yu Zhang, Zheng-Xin Liang, Hong-Feng Gou
Front Pharmacol. 2023; 14: 1190967. Published online 2023 Oct 13. doi: 10.3389/fphar.2023.1190967
PMCID:
PMC10603266
ArticlePDF–2.1M
11.
Transthyretin promotes the invasion of combined hepatocellular cholangiocarcinoma by tumor‐associated macrophages
Kun Ke, Junqing Lin, Ning Huang, Leye Yan, Rihua Liao, Weizhu Yang
Cancer Rep (Hoboken) 2023 Oct; 6(10): e1888. Published online 2023 Sep 9. doi: 10.1002/cnr2.1888
PMCID:
PMC10598247
ArticlePDF–2.8M
12.
Liver transplantation versus resection for patients with combined hepatocellular cholangiocarcinoma: A retrospective cohort study
Shizheng Mi, Ziqi Hou, Guoteng Qiu, Zhaoxing Jin, Qingyun Xie, Jiwei Huang
Heliyon. 2023 Oct; 9(10): e20945. Published online 2023 Oct 13. doi: 10.1016/j.heliyon.2023.e20945
PMCID:
PMC10590945
ArticlePDF–4.1M
13.
Incidental combined hepatocellular-cholangiocarcinoma in liver transplant patients: Does it have a worse prognosis?
Ender Anilir, Alihan Oral, Tolga Sahin, Fatih Turker, Yildiray Yuzer, Yaman Tokat
Hepatol Forum. 2023; 4(3): 97–102. Published online 2023 Sep 20. doi: 10.14744/hf.2022.2022.0037
PMCID:
PMC10564256
ArticlePDF–378K
14.
A Novel Mouse Model of Combined Hepatocellular-Cholangiocarcinoma Induced by Diethylnitrosamine and Loss of Ppp2r5d
Judit Domènech Omella, Emanuela E. Cortesi, Iris Verbinnen, Michiel Remmerie, Hanghang Wu, Francisco J. Cubero, Tania Roskams, Veerle Janssens
Cancers (Basel) 2023 Aug; 15(16): 4193. Published online 2023 Aug 21. doi: 10.3390/cancers15164193
PMCID:
PMC10453342
ArticlePDF–41M
15.
Liver transplantation for combined hepatocellular carcinoma and cholangiocarcinoma: A multicenter study
Jongman Kim, Dong-Jin Joo, Shin Hwang, Jeong-Moo Lee, Je-Ho Ryu, Yang-Won Nah, Dong-Sik Kim, Doo-Jin Kim, Young-Kyoung You, Hee-Chul Yu
World J Gastrointest Surg. 2023 Jul 27; 15(7): 1340–1353. Published online 2023 Jul 27. doi: 10.4240/wjgs.v15.i7.1340
PMCID:
PMC10405106
ArticlePDF–1.5M
16.
Case Report: Atezolizumab plus bevacizumab for combined hepatocellular-cholangiocarcinoma
Tomoyuki Satake, Taro Shibuki, Kazuo Watanabe, Mitsuhito Sasaki, Hiroshi Imaoka, Shuichi Mitsunaga, Motohiro Kojima, Masafumi Ikeda
Front Oncol. 2023; 13: 1234113. Published online 2023 Jul 21. doi: 10.3389/fonc.2023.1234113
PMCID:
PMC10401838
ArticlePDF–4.8M
17.
Synchronous Double Primary Combined Hepatocellular-cholangiocarcinoma and Cholangiolocarcinoma in a Cirrhotic Liver
Masahiro Sakata, Koji Kitada, Rika Omote, Hiroshi Sonobe, Masashi Utsumi, Naoyuki Tokunaga, Takashi Fushimi, Ryota Nagao, Tatsuro Sakata, Toshihiko Kaneyoshi, Tatsuya Toyokawa, Masaru Inagaki
J Clin Transl Hepatol. 2023 Aug 28; 11(4): 991–997. Published online 2023 Feb 8. doi: 10.14218/JCTH.2022.00382
PMCID:
PMC10318272
ArticlePDF–3.0M
18.
Correction: Propensity-matched analysis of patients with intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma and hepatocellular carcinoma undergoing a liver transplant
Ajacio Bandeira de Mello Brandão, Santiago Rodriguez, Alfeu de Medeiros Fleck Jr, Claudio Augusto Marroni, Mário B Wagner, Alex Hörbe, Matheus V Fernandes, Carlos TS Cerski, Gabriela Perdomo Coral
World J Clin Oncol. 2023 Jun 24; 14(6): 227–229. Published online 2023 Jun 24. doi: 10.5306/wjco.v14.i6.227
Corrects:
World J Clin Oncol. 2022 Aug 24; 13(8): 688–701.
PMCID:
PMC10311476
CorrectionPDF–698K
19.
Radiomics Based on Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Preoperative Differentiation of Combined Hepatocellular-Cholangiocarcinoma from Hepatocellular Carcinoma: A Multi-Center Study
Le Guo, Xijun Li, Chao Zhang, Yang Xu, Lujun Han, Ling Zhang
J Hepatocell Carcinoma. 2023; 10: 795–806. Published online 2023 Jun 2. doi: 10.2147/JHC.S406648
PMCID:
PMC10243611
ArticlePDF–2.4M
20.
An international multicentre evaluation of treatment strategies for combined hepatocellular-cholangiocarcinoma✰
Marco P.A.W. Claasen, Tommy Ivanics, Berend R. Beumer, Roeland F. de Wilde, Wojciech G. Polak, Gonzalo Sapisochin, Jan N.M. IJzermans
JHEP Rep. 2023 Jun; 5(6): 100745. Published online 2023 Mar 28. doi: 10.1016/j.jhepr.2023.100745
PMCID:
PMC10206495
ArticlePDF–3.8M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center